NSE IPO - Apply Online, Check Issue Date, Price, Lot Size & Allotment Status

Apply for NSE IPO:

Skip to main content

Live Entera Bio Ltd. Ordinary Shares Share Price Chart

O H L

Entera Bio Ltd. Ordinary Shares Performance Overview

Days Range
$2.98Low
$3.03High

Markets Today

Previous Close$3.03
Open$3.00
Volume76,409
Day's Range$2.98 - $3.03
52W Range$0.91 - $4.20
Market Cap$512.50 M

Historical Performance

1M Returns+4.84
3M Returns+150.41
6M Returns+126.12
1Y Returns+68.33
5Y Returns-37.14
10Y ReturnsNA

Entera Bio Ltd. Ordinary Shares Fundamentals

Market Cap$512.50 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$42.00 K
ROE TTM-1.08
EPS TTM$-0.35
Quarterly Earnings Growth YOYN/A
PB Ratio20.08
EBITDA$-11.50 M
Profit Margin-27235.71
Market Cap$512.50 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$42.00 K
ROE TTM-1.08
EPS TTM$-0.35
Quarterly Earnings Growth YOYN/A
PB Ratio20.08
EBITDA$-11.50 M
Profit Margin-27235.71

Entera Bio Ltd. Ordinary Shares Profit & Loss

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Total Revenue +$42.00 K$0$0$0$0$0
Gross Profit +$0$0$0$0$0$0
Operating Income -$2.56 M-$2.67 M-$3.26 M-$3.04 M-$3.54 M-$4.56 M
EBITDA -$2.56 M-$2.66 M-$3.25 M-$3.04 M-$3.53 M-$4.55 M
Interest Expense $0$12.00 K$0$0$0-$2.75 M
Depreciation $8.00 K$7.00 K$8.00 K$7.00 K$7.00 K$9.00 K
Income Before Tax -$2.57 M-$2.66 M-$3.20 M-$3.02 M-$3.50 M-$7.31 M
Income Tax Expense $0$0$0$0$0$0
Net Income +-$2.57 M-$2.66 M-$3.20 M-$3.02 M-$3.50 M-$7.31 M
Net Profit Margin -6111.9%-----

Entera Bio Ltd. Ordinary Shares Financials Balance Sheet In USD

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Share Capital $1.00 K$1.00 K$1.00 K$1.00 K$1.00 K$1.00 K
Reserve & Surplus -$116.45 M-$119.11 M-$122.31 M-$125.33 M-$128.83 M-$136.14 M
Non-Current Liabilities $598.00 K$567.00 K$602.00 K$689.00 K$866.00 K$10.11 M
Current Liabilities $1.62 M$1.84 M$1.57 M$2.20 M$1.58 M$2.10 M
Total Liabilities $2.22 M$2.41 M$2.17 M$2.89 M$2.44 M$12.21 M
Fixed Assets $57.00 K$79.00 K$114.00 K$134.00 K$127.00 K$121.00 K
Current Assets $21.22 M$19.31 M$17.01 M$15.30 M$12.49 M$18.90 M
Total Assets $21.60 M$19.67 M$17.41 M$15.99 M$13.13 M$19.48 M

Entera Bio Ltd. Ordinary Shares Cash Flow

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Net Income -$2.57 M-$2.66 M-$3.20 M-$3.02 M-$3.50 M-$7.31 M
Operating Cash Flow -$1.40 M-$1.63 M-$2.50 M-$1.83 M-$3.09 M-$3.46 M
Investing Cash Flow -$8.00 K-$29.00 K-$43.00 K-$27.00 K$0-$3.00 K
Financing Cash Flow $13.34 M-$51.00 K$250.00 K$174.00 K$130.00 K$9.96 M
Change in Cash $11.93 M-$1.71 M-$2.29 M-$1.72 M-$2.96 M$6.49 M

Entera Bio Ltd. Ordinary Shares Return Calculator

The Entera Bio Ltd. Ordinary Shares stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Returns Estimator

Based on past performance of this fund

ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$6,183
Invested Amount$10,000
Est. Returns$-3,817
Invest in USA Stock Today

About Entera Bio Ltd. Ordinary Shares

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to perform. Its product candidates are: EB613, which is being developed as an oral, osteoanabolic (bone-building) tablet treatment for osteoporosis; EB612, being developed as an oral PTH(1-34) tablet peptide replacement therapy for patients with hypoparathyroidism; EB618, an Oral GLP-1 being developed to tackle obesity; and Oral GLP-2, a peptide tablet alternative for patients suffering from short bowel syndrome. The company operates in Israel.

FAQs

Entera Bio Ltd. Ordinary Shares (ENTX) share price as of September 18, 2026 is $2.98. If you are investing from India, you can always check the valuation in the INR before investing.
Yes, Indian Investors can invest in the Entera Bio Ltd. Ordinary Shares (ENTX) Share by opening an international trading account with Angel One.
Purchasing Entera Bio Ltd. Ordinary Shares (ENTX) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Entera Bio Ltd. Ordinary Shares (ENTX) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Yes, you can purchase fractional shares of Entera Bio Ltd. Ordinary Shares (ENTX) or any other US company shares in Angel One for any dollar amount.
The market capitalization of Entera Bio Ltd. Ordinary Shares on September 18, 2026, is $512.50 M.
Entera Bio Ltd. Ordinary Shares operates in the Healthcare sector, specifically in the Healthcare industry.
In order to invest in Entera Bio Ltd. Ordinary Shares (ENTX) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.

Diversify Your Portfolio with US Stocks

Invest in Wall Street Giants from India

+91
Top US Stocks

VIEW ALL

Open Free Demat Account!

Join our 3.8 Cr+ happy customers
+91